You are here

Novartis mulls options including spinoff, IPO for Alcon unit

Thursday, January 26, 2017 - 05:50


NOVARTIS AG proposed buying back US$5 billion of shares and said it's considering separating its embattled eye-care division after projecting that sales this year at Europe's second-biggest drugmaker will likely be largely unchanged from 2016.

Earnings, excluding some

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom